AVOCENT CORP 4
4 · AVOCENT CORP · Filed Jul 27, 2005
Insider Transaction Report
Form 4
AVOCENT CORPAVCT
DeVore Dudley
Senr VP, Branded Markets, Amer
Transactions
- Exercise/Conversion
Common Stock
2005-07-26$20.82/sh+2,656$55,298→ 2,656 total - Exercise/Conversion
Options (rights to buy)
2005-07-26−2,656→ 0 totalExercise: $20.82From: 2001-03-12Exp: 2011-03-12→ Common Stock (2,656 underlying) - Sale
Common Stock
2005-07-26$35.00/sh−2,656$92,960→ 0 total
Holdings
- 14,499
Options (rights to buy)
Exercise: $34.67From: 2000-01-26Exp: 2010-01-26→ Common Stock (14,999 underlying) - 10,000
Options (rights to buy)
Exercise: $27.25From: 2003-03-07Exp: 2013-03-07→ Common stock (10,000 underlying) - 5,000
Options (rights to buy)
Exercise: $28.96From: 2004-08-19Exp: 2014-08-19→ Common stock (5,000 underlying) - 200
Options (rights to buy)
Exercise: $52.44From: 2000-09-18Exp: 2010-09-18→ Common stock (200 underlying) - 3,300
Options (rights to buy)
Exercise: $26.14From: 2005-06-30Exp: 2015-06-30→ Common Stock (3,300 underlying) - 4,688
Options (rights to buy)
Exercise: $21.77From: 2002-04-15Exp: 2012-04-15→ Common Stock (4,688 underlying)
Footnotes (5)
- [F1]Grant date, 5 year vesting, 20% annually beginning on first anniversary of grant date.
- [F2]Grant date, 2 year vesting, 50% annually beginning on first anniversary of grant date.
- [F3]Grant date, 4 year vesting, 25% on first anniversary of grant date, then 6.25% vests quarterly over the remaining 12 quarters.
- [F4]Grant date, 3 year vesting, 25% vests after 6 months, then 7.5% vests quarterly over the remaining 10 quarters.
- [F5]Grant date, 100% vests on December 31, 2005.